Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Castoldi, Francesca"'
Autor:
Castoldi F; Guido Kroemer: Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France; Université Pierre & Marie Curie, Paris, France; Université Paris-Sud/Paris XI, Faculté de Médecine, Kremlin-Bicêtre, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Pietrocola F; Guido Kroemer: Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France; Université Pierre & Marie Curie, Paris, France; Université Paris-Sud/Paris XI, Faculté de Médecine, Kremlin-Bicêtre, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Maiuri MC; Guido Kroemer: Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France; Université Pierre & Marie Curie, Paris, France; Université Paris-Sud/Paris XI, Faculté de Médecine, Kremlin-Bicêtre, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden., Kroemer G; Guido Kroemer: Gustave Roussy Cancer Campus, Villejuif, France; INSERM, U1138, Paris, France; Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France; Université Pierre & Marie Curie, Paris, France; Université Paris-Sud/Paris XI, Faculté de Médecine, Kremlin-Bicêtre, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Oncotarget [Oncotarget] 2018 May 15; Vol. 9 (37), pp. 24574-24575. Date of Electronic Publication: 2018 May 15 (Print Publication: 2018).
Autor:
Galluzzi L; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France., Vacchelli E; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France., Bravo-San Pedro JM; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France., Buqué A; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France., Senovilla L; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France., Baracco EE; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France., Bloy N; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France., Castoldi F; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France. Sotio a.c., Prague, Czech Republic., Abastado JP; Pole d'innovation thérapeutique en oncologie, Institut de Recherches Internationales Servier, Suresnes, France., Agostinis P; Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium., Apte RN; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Aranda F; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Group of Immune receptors of the Innate and Adaptive System, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Ayyoub M; INSERM, U1102, Saint Herblain, France. Institut de Cancérologie de l'Ouest, Saint Herblain, France., Beckhove P; Translational Immunology Division, German Cancer Research Center, Heidelberg, Germany., Blay JY; Equipe 11, Centre Léon Bérard (CLR), Lyon, France. Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France., Bracci L; Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Caignard A; INSERM, U1160, Paris, France. Groupe Hospitalier Saint Louis-Lariboisière - F. Vidal, Paris, France., Castelli C; Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Cavallo F; Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy., Celis E; Cancer Immunology, Inflammation and Tolerance Program, Georgia Regents University Cancer Center, Augusta, GA, USA., Cerundolo V; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Clayton A; Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK. Velindre Cancer Centre, Cardiff, UK., Colombo MP; Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Coussens L; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Dhodapkar MV; Sect. of Hematology and Immunobiology, Yale Cancer Center, Yale University, New Haven, CT, USA., Eggermont AM; Gustave Roussy Cancer Campus, Villejuif, France., Fearon DT; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA., Fridman WH; INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Equipe 13, Centre de Recherche des Cordeliers, Paris, France., Fučíková J; Sotio a.c., Prague, Czech Republic. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic., Gabrilovich DI; Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Galon J; INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France., Garg A; Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium., Ghiringhelli F; INSERM, UMR866, Dijon, France. Centre Georges François Leclerc, Dijon, France. Université de Bourgogne, Dijon, France., Giaccone G; Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Gilboa E; Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA., Gnjatic S; Sect. of Hematology/Oncology, Immunology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Hoos A; Glaxo Smith Kline, Cancer Immunotherapy Consortium, Collegeville, PA, USA., Hosmalin A; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. INSERM, U1016, Paris, France. CNRS, UMR8104, Paris, France. Hôpital Cochin, AP-HP, Paris, France., Jäger D; National Center for Tumor Diseases, University Medical Center Heidelberg, Heidelberg, Germany., Kalinski P; Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA. Dept. of Immunology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA., Kärre K; Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden., Kepp O; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France., Kiessling R; Dept. of Oncology, Karolinska Institute Hospital, Stockholm, Sweden., Kirkwood JM; University of Pittsburgh Cancer Institute Laboratory, Pittsburgh, PA, USA., Klein E; Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden., Knuth A; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar., Lewis CE; Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology, University of Sheffield Medical School, Sheffield, UK., Liblau R; INSERM, UMR1043, Toulouse, France. CNRS, UMR5282, Toulouse, France. Laboratoire d'Immunologie, CHU Toulouse, Université Toulouse II, Toulouse, France., Lotze MT; Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA., Lugli E; Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy., Mach JP; Dept. of Biochemistry, University of Lausanne, Epalinges, Switzerland., Mattei F; Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Mavilio D; Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy. Dept. of Medical Biotechnologies and Translational Medicine, University of Milan, Rozzano, Italy., Melero I; Dept. of Immunology, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain. Dept. of Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Melief CJ; ISA Therapeutics, Leiden, The Netherlands. Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Mittendorf EA; Research Dept. of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Moretta L; Istituto Giannina Gaslini, Genova, Italy., Odunsi A; Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA., Okada H; Dept. of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Palucka AK; The Jackson Laboratory for Genomics Medicine, Farmington, CT, USA., Peter ME; Div. of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Pienta KJ; The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA., Porgador A; The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Prendergast GC; Lankenau Institute for Medical Research, Wynnewood, PA, USA. Dept. of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Philadelphia, PA, USA. Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Rabinovich GA; Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Buenos Aires, Argentina., Restifo NP; National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA., Rizvi N; Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA., Sautès-Fridman C; INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Equipe 13, Centre de Recherche des Cordeliers, Paris, France., Schreiber H; Dept. of Pathology, The Cancer Research Center, The University of Chicago, Chicago, IL, USA., Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany., Shiku H; Dept. of Immuno-GeneTherapy, Mie University Graduate School of Medicine, Tsu, Japan., Silva-Santos B; Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal., Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia., Speiser DE; Dept. of Oncology, University of Lausanne, Lausanne, Switzerland. Ludwig Cancer Research Center, Lausanne, Switzerland., Spisek R; Sotio a.c., Prague, Czech Republic. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic., Srivastava PK; Dept. of Immunology, University of Connecticut School of Medicine, Farmington, CT, USA. Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, USA., Talmadge JE; Laboratory of Transplantation Immunology, Dept. of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Tartour E; Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. INSERM, U970, Paris, France. Paris-Cardiovascular Research Center (PARCC), Paris, France. Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France., Van Der Burg SH; Dept. of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Van Den Eynde BJ; Ludwig Institute for Cancer Research, Brussels, Belgium. de Duve Institute, Brussels, Belgium. Université Catholique de Louvain, Brussels, Belgium., Vile R; Dept. of Molecular Medicine and Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA., Wagner H; Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany., Weber JS; Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, FL, USA., Whiteside TL; University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Wolchok JD; Dept. of Medicine and Ludwig Center, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. Weill Cornell Medical College, New York, NY, USA., Zitvogel L; Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1015, Villejuif, France. Centre d'Investigation Clinique Biothérapie 507 (CICBT507), Gustave Roussy Cancer Campus, Villejuif, France., Zou W; University of Michigan, School of Medicine, Ann Arbor, MI, USA., Kroemer G; Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France.
Publikováno v:
Oncotarget [Oncotarget] 2014 Dec 30; Vol. 5 (24), pp. 12472-508.